Pharmaceutical Services Federal Committee of Inquiry

Provisions for the Pharmaceutical Services Committee of Inquiry are under the National Health Act 1953. The Act allows a Committee to be established at either a state or federal level. The current Federal level committee was established in 2015 to investigate matters of suspected non-compliance with a pharmacist's approval to supply Pharmaceutical Benefits Scheme (PBS) medicines, including the conditions of approval. In particular, where PBS medicines are being supplied at premises for which the pharmacist is not approved. The Act specifies the membership of the Committee consists of four pharmacists appointed by the Minister for Health and Aged Care as well as the Secretary of the Department of Health and Aged Care (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).